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ABSTRACT
Circadian rhythms orchestrate biochemical and physi-
ological processes in living organisms to respond the
day/night cycle. In mammals, nearly all cells hold self-
sustained circadian clocks meanwhile couple the
intrinsic rhythms to systemic changes in a hierarchical
manner. The suprachiasmatic nucleus (SCN) of the
hypothalamus functions as the master pacemaker to
initiate daily synchronization according to the photope-
riod, in turn determines the phase of peripheral cellular
clocks through a variety of signaling relays, including
endocrine rhythms and metabolic cycles. With aging,
circadian desynchrony occurs at the expense of
peripheral metabolic pathologies and central neurode-
generative disorders with sleep symptoms, and genetic
ablation of circadian genes in model organisms resem-
bled the aging-related features. Notably, a number of
studies have linked longevity nutrient sensing pathways
in modulating circadian clocks. Therapeutic strategies
that bridge the nutrient sensing pathways and circadian
clock might be rational designs to defy aging.
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INTRODUCTION
With seminal successes in biomedical researches, the
improved medical conditions markedly lengthened human
lifespan however also led to emerging threats as known the
age-associated complexities (Kaeberlein et al., 2015). The
wide range of age-associated diseases, including neurode-
generative diseases, cardiovascular disorder, type-2 dia-
betes, and higher cancer incidences, are driven by the
causes of time, genetic and environmental situations that
remain difﬁcult to dissect for major effector(s) in individuals.
Over decades, researches on aging have revealed the
retardation of physiological decline and lifespan extension
are conceivable by genetic perturbations in model organ-
isms, the results now offered potential therapeutic strategies
to prolong both healthspan and lifespan (Lopez-Otin et al.,
2016). Dietary restriction (DR), a chronic reduction of dietary
intake regime was proven as a major link of connecting
these genetic longevity studies. DR increases lifespan in
many model organisms, including budding yeast Saccha-
romyces cerevisiae, nematode Caenorhabditis elegans, and
fruitﬂy Drosophila melanogaster. These relatively simpliﬁed
models rendered further analyses of longevity genes and
pathways that are activated upon low-energy challenges
thus mimicked DR effects (Fontana and Partridge, 2015;
Guarente, 2013). Importantly, salutary effects of DR is evo-
lutionarily conserved as also observed in primates (Colman
et al., 2009; Colman et al., 2014). The signiﬁcance of DR
emphases the idea that energy homeostasis is centered in
longevity, while aging is largely caused by aberrant energy
condition and metabolic inﬂexibility (Riera and Dillin, 2015).
Thus interactions among calorie intake, meal frequency and
timing, as organized by the daily circadian rhythm program,
are likely key to maintain the cellular and organ ﬁtness.
Circadian rhythms govern a wide range of physiological
and behavioral systems, such as energy metabolism, sleep-
wake cycles, body temperature and locomotor activity
(Panda et al., 2002; Reppert and Weaver, 2002). Declined
circadian rhythmicity in endocrine rhythm, phase alignment
and sleep are commonly seen with aging (Mattis and Sehgal,
2016). Consistently, experimental disruptions of circadian
rhythms seriously impede functional physiology, lifespan and
endorse cancer incident (Filipski et al., 2003; Froy, 2013; Fu











et al., 2002; Kondratova and Kondratov, 2012; Penev et al.,
1998). Even a milder circadian challenge, chronic jet-lag,
imposes on aged wild-type mice can markedly increase
mortality (Davidson et al., 2006). On the other hand, implant
functional circadian clock with fetal suprachiasmatic nucleus
in aged rodents allowed higher amplitude rhythm behavior
and longer surviorship (Hurd and Ralph, 1998; Li and Sati-
noff, 1998). The evidence pictured the pivotal contributions
of robust circadian rhythms in upholding the healthy physi-
ology and likely the extension of lifespan.
This review includes an overview of the molecular
mechanism of circadian control, and molecular deﬁciencies
implicated in age-related malfunctions. It discusses the
central circadian clock system and the pathologies with
aging, including the impacts to neurodegenerative diseases
and sleep. Finally, advises the links of circadian components
to energy-sensing pathways that modulate mammalian
lifespan, furthermore their potential as therapeutic targets to
treat age-associated loss in physiological homeostasis.
MOLECULAR OSCILLATORS IN THE CIRCADIAN
CLOCK
Circadian oscillations are generated via transcriptional–
translational feedback loops in a cell autonomous manner in
mammals (Bass and Takahashi, 2010; Dibner et al., 2010).
The core transcription factors CLOCK and BMAL1
heterodimerize and bind to E-box motif-containing clock-
controlled genes (CCGs) in a time-dependent manner. There
are at least two interconnected feedback loops involved in
the transcriptional regulation (Fig. 1). In the primary feedback
loop, CLOCK:BMAL1 initiates the transcription of Period
(Per) and Cryptochrome (Cry) through the binding of E-box
elements. The transcriptional control is also facilitated by
recruiting various coactivators including CBP/p300 (Hosoda
et al., 2009; Li et al., 2010), TRAP150 (Lande-Diner et al.,
2013) and SRC-2 (Stashi et al., 2014). When CRYs and
PERs proteins accumulate to critical levels, they assemble
into hetero-complexes and function as corepressors via
direct binding to CLOCK:BMAL1 thus repress their own
expression. The repression is facilitated by posttranslational
modiﬁcations, for instance phosphorylation of PERs for
nuclear translocation hence binding to CLOCK:BMAL1 (Lee
et al., 2001). The repression is later relieved by the degra-
dation of CRYs and PERs over time, allows another circa-
dian cycle of CRYs and PERs expressions taking place. In
the secondary loop, the nuclear orphan receptors REV-
ERBα, REV-ERBβ, RORα, RORβ and RORγ are involved in
controlling the temporal expression of BMAL1 and CLOCK.
Of note, these nuclear orphan receptors are also CCGs
under CLOCK:BMAL1 regulation. By recognizing RORE
elements within the promoters of Bmal1 and Clock genes,
ROR collaborates with PGC-1α to transcriptionally activate
Bmal1 and Clock. REV-ERB competes for the RORE binding
at circadian times with concentration advantage over ROR,
and executes as BMAL1 and CLOCK repressor (Cho et al.,
2012; Preitner et al., 2002; Sato et al., 2004). The repressing
activity requires the recruitment of a NCoR1-HDAC3 core-
pressor complex (Everett and Lazar, 2014). Recent ﬁndings
of hypoxia-inducible factor 1α (HIF1α) in additional regula-
tory route indicated oxygen level is an auxiliary cue in clock.
HIF1α itself is a CCG and at hypoxia, activates per expres-
sion via binding to the hypoxia-responsive element (HRE) in
a complex with ARNT. The results are of clinical interests to
cardioprotection and phase conditions such as jetlag (Ada-
movich et al., 2017; Peek et al., 2017; Wu et al., 2017). Other
transcriptional regulations in particular cell types, for
instance ZBTB20 in rhythmic expression of prokineticin
receptor-2 (Prokr2) in the suprachiasmatic nucleus neurons,
is critical for the bimodal activity behavior in mice (Qu et al.,
2016). It will be important to decipher known, or identify new
regulatory mechanisms in cell types that are responsible for
unique circadian behaviors.
Notably, both the primary and secondary feedback loops
are modulated by post-translational modiﬁcations in versatile
ways, e.g, protein ubiquitination, phosphorylation/dephos-
phorylation, acetylation/deacetylation, poly ADP-ribosylation
and O-GlcNAcylation (Reddy and Rey, 2014). These modi-
ﬁcations indicate evident basis linking circadian and meta-
bolic cycles at timely manner. Identify new post-translation
modiﬁcations and classify the modiﬁcations in the central
Figure 1. Molecular oscillators in circadian control.
(A) Transcription factor complex CLOCK:BMAL1 binds to
E-box containing motifs, allows the transcriptional activa-
tion of clock-controlled genes (CCGs) such as Pers, Crys,
Ror and Rev-Erb. The activation is facilitated by recruiting
coactivators such as CBP/p300. CCG transcriptions are as
well regulated by transcription factors relaying the external
cues. Examples include cAMP responsive element binding
protein (CREB), heat shock factor 1 (HSF1), hypoxia-
inducible factor 1α (HIF1α) and glucocorticoid receptor
(GR) that bind to their respective regulatory elements
(Bollinger and Schibler, 2014; Wu et al., 2016). Two
interconnected feedback loops involved in the circadian
transcriptional regulation. In the primary feedback loop,
PER and CRY assemble into repressor complexes next
attenuate the activity of CLOCK:BMAL1. In the second
feedback loop, ROR (also a CCG protein) can complex
with coactivator PGC-1α and bind to RORE element for
Bmal1 (and likely Clock) activation(s). REV-ERB works as
a repressor in Bmal1 transcription by concentration-
dependent competition at the same RORE sequence.
The repression involved the recruitment of NCoR/HDAC3
corepressor complexes. (B) Energy sensors such as
Sirtuins, AMPK and mTOR participate in circadian modu-
lations via post-translational modiﬁcation of circadian
components, as depicted in (A). Interventions target the
pathways are of potential to treat age-associated circadian
amplitude decline and phase mis-alignment.
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and peripheral tissues will be of great value to understand
circadian physiology.
CLOCK GENES AND AGE-RELATED DISORDERS
Aging is a major risk factor for many human pathologies,
including cancer, diabetes, cardiovascular disorders and
neurodegenerative diseases (Lopez-Otin et al., 2013).
Genetic models of circadian disruption pheno-copied aging
and metabolic disorders frequently. A prominent case is the
loss of BMAL1. Mice deﬁcient for Bmal1 are suffered from a
series of conditions related to aging. e.g., sarcopenia (with
both reduction in muscle ﬁber size and quantity), cataracts,
cornea inﬂammation, osteoporosis, premature hair loss, and
failed to form adequate visceral and subcutaneous adipose
storage (Kondratov et al., 2006). The strain is severely short-
lived with average lifespan of 37.0 ± 12.1 weeks, compared
to longer than 110 weeks of lifespan in same background
wild type animals (Nadon, 2006). The ﬁndings coordinate
well with the roles of BMAL1 in homeostatic maintenance of
the glucose level (Rudic et al., 2004), and in adipogenesis
regulation (Shimba et al., 2005). Consistently, it has been
noticed that Bmal1 mRNA amplitude declined with altered
peak phase in natural aging in rodents (Kolker et al., 2003).
As a reciprocal component of BMAL1, CLOCK deﬁciency
also results in shorter average lifespan to approximately
15% reduction compared to wild type, and premature
pathologies including cataracts and dermatitis (Dubrovsky
et al., 2010). CLOCK appears to be crucial in glucose
homeostasis as well, as both whole body and conditional
disruptions of CLOCK caused hypoinsulinaemia hence dia-
betes mellitus in rodents. Same study demonstrated BMAL1
is also participated in sustaining the pancreatic clock
(Marcheva et al., 2010). Of note, ClockΔ19 strain, the
CLOCK truncated line that was originally identiﬁed for its
signiﬁcant period change from a random mutagenesis
screen, is with milder aging phenotypes such as diurnal
activity/feeding rhythms and obesity in normal housing
conditions compared to the knockout strain (Turek et al.,
2005). Additional challenges such as post ionizing irradiation
triggered an accelerated aging program in the strain (Antoch
et al., 2008). The results suggested that the particular
CLOCK truncation might be partially functional in protecting
from premature aging, at a condition that the intrinsic period
is far from optimal. Loss of PER2, a core circadian compo-
nent, is linked to cancer predisposing. The animals are
sensitive to γ irradiation later developed salivary gland
hyperplasia, teratoma and malignant lymphomas (Fu et al.,
2002). Further, genetic ablation of both Per1 and Per2
caused an arrhythmic phenotype together with premature
aging conditions, e.g., early decline in fertility, kyphosis and
predisposed tumor incidences (Lee, 2005). The DNA dam-
age response and p53-mediated apoptosis are defective in
these animals. The studies demonstrated that circadian
clock components are also important regulators in cell cycle
and proliferation likely speciﬁc in adulthood, as the double
knockouts seem developmentally normal at birth. Another
component CRY1 is shown to modulate hepatic gluconeo-
genesis by regulating the cAMP signaling. Rhythmic
expression of CRY1 directly adjusts intracellular cAMP
concentrations and the phosphorylation level of cAMP
response element-binding protein (CREB) by protein kinase
A (Zhang et al., 2010). Lipid metabolism is linked to circadian
clock in the cases of REV-ERB and ROR families. They are
important for regulating lipogenesis, lipid storage and adi-
pocyte differentiation in a rhythmic manner (Bray and Young,
2007; Chawla and Lazar, 1993; Torra et al., 2000). REV-
ERBs act as decent targets in treating obesity. The agonists
work against fat mass accumulation in high fat fed mice,
consequently improve dyslipidemia and hyperglycemia (Cho
et al., 2012; Solt et al., 2012).
The role of circadian genes in Cancer Biology remains to
be a complicated conundrum. As contrast to the tumor
suppressing effect of PER2, deletion of Cry1/2 in p53 null
mice protected the early onset of cancer incidence, and
sensitized the p53 deﬁcient cells to apoptosis upon geno-
toxic stress (Ozturk et al., 2009). A recent ﬁnding of targeting
BMAL1 and CLOCK for acute myeloid leukemia (AML)
therapy indicates further the pro-cancerous option of clock
components (Puram et al., 2016). Many core circadian pro-
teins are involved in the cell cycle and the DNA damage
response (Sahar and Sassone-Corsi, 2009), thus may
facilitate the proliferation of transformed malignant cancer
cells while normal post-mitotic cells should be exempted
from the risk. Careful analyses of cancer types and the
associations to circadian gene alterations are essential to
address the paradox.
THE CENTRAL CIRCADIAN CLOCK SYSTEM
To organize physiology and behavior for proper functioning
according to the 24-hour environmental light/dark cycle,
mammals rely on a central pacemaker known as the
suprachiasmatic nucleus (SCN) for systemic synchroniza-
tion. SCN resides at the anterior hypothalamus and directly
contacts optic chiasm for sensing the external photic input. It
is composed by paired nuclei lateral to either side of the third
ventricle (Colwell, 2011). Though with limited neurons
(∼20,000 in mouse), SCN contains considerable neuron
heterogeneity. There includes calretinin, neurotensin (NT),
gastrin releasing peptide (GRP), angiotensin II, prokineticin 2
(PK2), neuromedin S (NMS), vasoactive intestinal peptide
(VIP) and arginine vasopressin (AVP) expressing neurons
(Welsh et al., 2010). Among them VIP and AVP neurons are
key neuron types that mark the ventral core and dorsal shell
subdivisions of SCN, respectively (Golombek and Rosen-
stein, 2010). Most SCN neurons are GABAergic (Moore and
Speh, 1993; Morin et al., 2006).
Neurons in the core are considered to incorporate exter-
nal inputs, such as photic light cue from the retinohypotha-
lamic tract (RHT), and likely also the projections from the
raphe nuclei (Morin and Allen, 2006). The environmental
REVIEW Fang Liu and Hung-Chun Chang









information is then coupled and communicated to the rest
parts of the SCN (Fig. 2). Among the core neurons, VIP
neuron is essential in the SCN oscillation coupling; likewise
GRP, NT neurons and neurotransmitter GABA contribute
signiﬁcantly to the process as well (Aida et al., 2002; Choi
et al., 2008; De Jeu and Pennartz, 2002; Meyer-Spasche
et al., 2002; Shinohara et al., 2000). The sensory core
neurons display lesser clock gene expression amplitudes,
perhaps is suitable for faster resetting when respond to
environmental changes, as has been predicted in mathe-
matical modeling work (Pulivarthy et al., 2007). This is by
contrast to AVP, PK2, and even GABAergic neurons in the
dorsal shell SCN that circadian genes including Per1 and
Per2 are robustly oscillated in the subdivision (Hamada























































































Figure 2. Schematic functional map of circadian control. Studies have demonstrated the SCN efferent primarily travel to other
hypothalamic nuclei incuding dorsomedial hypothalamus (DMH), subparaventricular zone (sPVZ) and more. A map of direct SCN
neuron projections to sleep-awake or cognitive centers in the brain (A) and the intra-SCN (bilateral) connectomes (B), with the details
in connection density and neuron types, remains elusive at the moment.
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It has been observed that most of the projections from the
core terminate within the shell, stresses the point that the
interplay between the two regions is most important among
all circadian outputs from the SCN (Antle and Silver, 2005).
Several studies have demonstrated the SCN efferent from
both core and shell travel chieﬂy to other hypothalamic
nuclei, e.g., dorsomedial hypothalamus (DMH), paraven-
tricular hypothalamic nucleus (PVN), arcuate hypothalamic
nucleus (ARC), subparaventricular zone (sPVZ), and more
(Abrahamson and Moore, 2001; Kalsbeek et al., 2006; Yan
et al., 2007). The projections cover the nervous and endo-
crine systems for temporal control of the daily oscillation in
the body (Dibner et al., 2010). Notably, the projections to
central sleep system, for example the ventrolateral preoptic
area (VLPO), locus coeruleus (LC) and lateral hypothalamus
(LH), are suggested as indirect or sparse (Abrahamson
et al., 2001; Aston-Jones et al., 2001; Chou et al., 2002;
Novak and Nunez, 2000). This postulates either the sparse
connections are sufﬁcient for temporal cues to structure the
sleep program, or there exists a central hub, such as DMH,
for the communications in between (Chou et al., 2003; Mattis
and Sehgal, 2016). A thorough SCN map with neuron type
accuracy via connectome works will be of great help to
elucidate the functional circadian circuitry (Fig. 2).
AGE-ASSOCIATED DECLINE IN CENTRAL
CIRCADIAN SYSTEM
Important features of functional circadian rhythms include,
e.g., sustaining at a sufﬁcient oscillation amplitude through
out the daily cycle; composing a phase that is properly
aligned with the light/dark condition and can be entrained by
light; and maintaining in a near 24 h period to reﬂect the
Earth day (Bass and Takahashi, 2010; Welsh et al., 2010).
Aging hampers amplitude both in circadian gene expres-
sions (Hofman and Swaab, 2006; Yamazaki et al., 2002),
and several physical indexes including melatonin level,
sleep-wake disruptions, lowered locomotor activity (Duffy
and Czeisler, 2002; Valentinuzzi et al., 1997; Weinert, 2000;
Yoon et al., 2003). Further, phase shifts and re-entrainment
difﬁculty are also common drawbacks with aging (Gibson
et al., 2009; Scarbrough et al., 1997; Valentinuzzi et al.,
1997). While many factors account for these physical
changes, the central clock SCN is likely to stand as a key
element responsible for this age-related decline.
The central clock SCN decay, considering the direct or
indirect contacts to variable brain regions, would reveal
degeneration in at least two aspects: the SCN projections,
and secreted signals from the SCN. While projection details
of young versus old await careful investigations, SCN
secreting outputs have been studied. For example, aging
affects SCN prominently in the AVP neuron population. In
human, diurnal oscillation of the neuropeptide in young is
evident, but in elderly people (over 50 years of age) the
change becomes subtle. Further, the peaking time in the
early morning in young is reversed to low-amplitude night
peaking in the elderly (Hofman and Swaab, 1994). Interest-
ingly, the annual cycle of AVP expression is also lost with
aging. Young subjects are normally with lowest AVP-im-
munoreactive values during the summer and highest in
autumn (Hofman and Swaab, 1995). These results suggest
that the activities of human SCN, both for the diurnal and the
seasonal rhythms, become disturbed later in life. VIP neuron
is another, perhaps more sensitive, example to reﬂect
human SCN aging. In young male subjects (10–40 years),
the number of VIP neurons in the SCN is highest. However
in the age of 40–65 years old, the VIP neuron number dra-
matically decreased by about 60% further does not show
signiﬁcant decline in later ages (Hofman et al., 1996; Zhou
et al., 1995).
Studies in rodents offered further evidences for SCN
activity change. First, the AVP neuron is signiﬁcantly
reduced in aged rats while the total SCN neuron number
stayed similar (Roozendaal et al., 1987), a change reminis-
cent to the human case. SCN neurons become desynchro-
nized and are with decreased phase coherence with aging
(Farajnia et al., 2012). In vivo multiunit neural activity (MUA)
recordings in the SCN in young (3–5 months) versus aged
(13–18 months) mice revealed that the day and night
amplitude differences in the older are signiﬁcantly reduced.
Similar decline in neural activity rhythms was also observed
in the subparaventricular zone, one of the major SCN output
regions (Nakamura et al., 2011). Whether molecular clock
components are good indicators for SCN aging remain
unclear. Nakamura et al. applied PER2 as the molecular
marker and only revealed subtle change in the two groups,
suggested the electrical activity rhythm is the more sensitive
circadian output measurement compared to molecular
components of the clock. Of note, other experiments showed
signiﬁcant age-related decline of BMAL1 and CLOCK in the
SCN as well in few other brain areas, when compared 4
versus 16 month-old mice (Wyse and Coogan, 2010). Fur-
ther characteristic analyses on SCN aging are crucial to
reason the basis of circadian dampens.
CIRCADIAN DISRUPTION AND
NEURODEGENERATIVE DISEASES
Circadian disorders with sleep symptoms are commonly
seen in patients with neurodegenerative diseases (Kondra-
tova and Kondratov, 2012). For instance, Parkinson’s dis-
ease (PD) patients are disrupted for the cortisol and
melatonin rhythms (Breen et al., 2014; Videnovic et al.,
2014), and displayed Bmal1 reduce in blood samples from
PD patients (Cai et al., 2010), these all point toward the
deteriorated situations in circadian control. A PD transgenic
model via Thy-1 promoter mediated α-synuclein over-ex-
pression exhibited several circadian phenotypes in aging: a
clear reduced wheel-running activity with altered period,
altered temporal distribution of sleep, and decayed
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spontaneous neural activity in the SCN, suggested circadian
rhythm is severely disrupted in the PD model (Kudo et al.,
2011).
Another PD model also links phenotypes to circadian
impairments. The strategy is to selectively inactivate mito-
chondrial transcription factor A (Tfam) in dopamine neurons
thus mimics PD progression particularly for dopamine neu-
ron degeneration. The conditional knockouts have reduced
physical activity as early as by 5 months of age, and then
dampened for both circadian amplitude and stability. The
animals also showed abolished rhythmic locomotion in
constant dark or constant light conditions (Fifel and Cooper,
2014). Besides circadian phenotypes, sleep disturbance is
another hallmark during PD progression. Several sleep dis-
orders are discovered in PD patients, including insomnia,
restless leg syndrome and REM behavior disorder (RBD), a
symptom that permits motor activity during REM sleep
(Barone et al., 2009; Iranzo, 2013). RBD is potentially useful
for the prediction of PD onset, as PD pathology occurs in the
brainstem earlier than the substantia nigra (Braak et al.,
2004). Loss of hypocretin neurons in the lateral hypothala-
mus could also explain the malfunction of sleep/arousal
program in PD patients (Fronczek et al., 2007).
Alzheimer’s disease (AD) patients are long recognized for
SCN neuronal loss, of that VIP neuron is a prominent case
(Swaab et al., 1985; Zhou et al., 1995). A recent analysis of
actogram associated to post-mortem brain tissue demon-
strated that besides locomotor activity phenotype, AD
patients are also diagnosed with false rhythmic control of
core-body temperature and rest-activity (Satlin et al., 1995;
van Someren et al., 1996). Sleep–wake cycle dysfunction
and increased daytime sleepiness are regard as risk factors
for AD related dementia (Lee et al., 2007). Consistently, the
transgenic 3xTg-AD mouse strain that exhibits both Aβ and
tau pathology (as in human AD) were scored for similar cir-
cadian phenotypes. The results indicated that prior to AD
pathology, activity during daytime and period change were
observed in the transgenic, interesting more in the males.
The number of VIP neuron is decreased in the SCN, sug-
gested again that circadian dysfunction is predictive in early
AD onset (Sterniczuk et al., 2010a; Sterniczuk et al., 2010b).
Patients with Huntington’s disease (HD) have sleep
symptoms including advanced sleep phase, insomnia and
reduced REM sleep (Arnulf et al., 2008; Goodman and
Barker, 2010). Neuropathological analyses demonstrated
that HD patients are depleted for many hypothalamic neu-
ropeptides, i.e., AVP, oxytocin and hypocretin, hence dis-
turbed regular sleep/awake daily cycle (Aziz et al., 2008;
Gabery et al., 2010). The HD model, R6/2 transgenic strain
displayed reduced expression of Per2 and blunted oscillation
of Bmal1 in the SCN, as well reduced in motor cortex and
striatum. The increased daytime activity is likely associated
with reduced prokineticin 2 expression that is critical for
suppressing daytime activity in nocturnal animals (Morton
et al., 2005). VIP and VPAC2 receptor are down regulated in
R6/2 animals in the SCN (Fahrenkrug et al., 2007).
Together, the ﬁndings indicate circadian parameters can
serve as the basis for prognostic purposes. Sustaining efﬁ-
cient circadian activities are likely key to prevent age-related
disorders, including neurodegenerative diseases.
LONGEVITY MEDIATORS IN CIRCADIAN
REGULATION
Vast amount of evidences have pointed out the importance
of circadian rhythm in functional physiology, however data
that are suggestive to longevity remain unclear. Our current
understandings mostly based on loss-of-function studies
(Eckel-Mahan et al., 2013), while genetic manipulation of
circadian gene has yet been reported with lifespan extension
outcome. Interestingly, many longevity mediators and path-
ways exert the beneﬁcial effects via cooperating with multi-
ple circadian components. One evident example is Sirt1, a
longevity gene that mediates calorie restriction (CR) beneﬁts
(Guarente, 2013), is involved in circadian regulation (Chang
and Guarente, 2014; Jung-Hynes et al., 2010). SIRT1 is a
NAD+-dependent deacetylase that is involved in regulating
circadian gene transcriptions via deacetylating histone H3
K9/K14 at the promoters regions (Nakahata et al., 2008). It
had been suggested that CLOCK works as a histone
acetyltransferase (HAT) in BMAL1 acetylation to facilitate
rhythmic circadian gene transcriptions (Hirayama et al.,
2007). SIRT1 appears to counterbalance the BMAL1
acetylation status in both ﬁbroblast culture and the liver
(Nakahata et al., 2008). Alternatively, SIRT1 deacetylates
PER2 thus regulates PER2 stability further adjusts the cir-
cadian feedback inhibition (Asher et al., 2008). Notably, the
synthesis of SIRT1 cofactor NAD+ also follows a circadian
expression pattern. Nicotinamide phosphoribosyltransferase
(NAMPT), the rate-limiting enzyme for NAD+ salvage path-
way, is a rhythmically expressed protein that under E-box
transcriptional control (Nakahata et al., 2009; Ramsey et al.,
2009). Together with facts that SIRT1 oscillates in a circa-
dian manner, and the level of NAD+ declines with aging
(Gomes et al., 2013), SIRT1 in the interconnected loops
revealed a strong correlation between energy and circadian
rhythms.
SIRT1 has been demonstrated for numerous vital roles in
upholding neuronal health, including neuronal development,
memory formation and neurodegenerative disease preven-
tions (Herskovits and Guarente, 2014). Owing to the critical
function of hypothalamus in metabolic regulations, many
SIRT1 related studies have been carried out in different
hypothalamic nuclei. For instance, SIRT1 activities are
important for POMC neuron in the ARC, and for SF1 neuron
in the VMH to maintain systemic glucose homeostasis hence
prevent obesity (Ramadori et al., 2011; Ramadori et al.,
2010). A transgenic strain overexpressing SIRT1 in DMH
and LH showed improved sleep quality with extended lifes-
pan (Satoh et al., 2013). In the SCN, SIRT1 prevents age-
associated circadian phenotypes via supporting molecular
oscillation of clock genes (Chang and Guarente, 2013). Of
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note, SIRT6 (a SIRT1 homolog) also participates in circadian
regulation of fatty acid and cholesterol metabolism (Masri
et al., 2014). Whether new post-translational modiﬁcations
take place in circadian modulation, perhaps link to the ver-
satile activities found in other sirtuins (Choudhary et al.,
2014), is of great interest to pursue in the future.
Adenosine monophosphate-activated protein kinase
(AMPK), another longevity mediator that is important for
sensing low energy state, contribute to relieve the PER/CRY
mediated circadian feedback repression. AMPK phospho-
rylates and activates casein kinase I epsilon (CKIε) for the
subsequent phosphorylation of PER, therefore promote PER
degradation (Um et al., 2007). In a similar action, AMPK
phosphorylates CRY directly and facilitates CRY degrada-
tion (Lamia et al., 2009). The stimulation of AMPK activity
leads to a phase advance effect. AMPK has been studied in
many hypothalamic nuclei such as ARC, VMH and DMH, for
energy balance and metabolism control (Lopez et al., 2016),
yet the role in central circadian regulation in the SCN
remains unclear.
The mammalian target of rapamycin (mTOR), an impor-
tant sensor of insulin, growth factor, and mitogen inputs, has
been revealed in circadian control through many effector
proteins. For instance ribosomal S6 protein kinase 1 (S6K1),
an important regulator of translation acting downstream of
mTOR activation, can rhythmically phosphorylate BMAL1.
The particular modiﬁcation allows BMAL1 to work as a
translation factor in a timely manner with response to the
mTOR signaling, in addition to the canonical role in circadian
transcription (Lipton et al., 2015). Of note, BMAL1 deﬁciency
caused elevated activity of mTORC1 both in cell culture and
in vivo. In vivo administration of the mTORC1 inhibitor
Rapatar increased Bmal1 null mice lifespan by 50% (Khapre
et al., 2014), the results suggested complex, bi-directional
regulations may exist between BMAL1 and mTOR. In the
SCN, the photic signal activates mTOR signaling and pro-
motes the translation of VIP by repressing 4E-BP1.
Accordingly, the 4E-BP1 deﬁcient mice exhibit accelerated
re-entrainment upon light/dark shift and are more resilient to
constant light mediated circadian disruption (Cao et al.,
2013). Together, the ﬁndings reveal strong energy links
among aging, metabolism and circadian physiology.
CONCLUDING REMARKS
It is clear that age-related diseases such as cancer, type-2
diabetes, obesity and neurodegenerative disorders are pro-
foundly metabolic-associated (Lopez-Otin et al., 2013), and
functional circadian activities maybe key to preclude the
abnormalities (Asher and Sassone-Corsi, 2015). Numerous
data indicate nutrient-sensing/longevity pathways such as
SIRT1 and others assist circadian control, and impose reg-
ulatory loops in coordinating photic and non-photic feeding
stimuli. The beneﬁcial effects offered viewpoints that inter-
ventions for promoting healthy aging and longevity may as
well treat circadian disorders. Initiated trials on sirtuin-
activating compounds (STACs) such as resveratrol,
SRT2104 or NAD+ precursors (Bonkowski and Sinclair,
2016; Wood et al., 2004); metformin for AMPK activation
(Barzilai et al., 2016); and rapamycin for mTOR inhibition
(Harrison et al., 2009; Li et al., 2014) are suitable candidates
for such interventions. Effects of these on central versus
peripheral clocks, and the underlying mechanisms await
careful analyses in the future.
ACKNOWLEDGEMENTS
We thank Y.-C. Tang and the members in Chang laboratory for
discussions. We are grateful to members of the Chang laboratory for
their critical reading of the manuscript. H.-C. Chang is supported by
General Program of National Natural Science Foundation of China
(Grant No. 31671221) and Chinese Academy of Sciences
(2013OHTP03).
ABBREVIATIONS
AD, Alzheimer’s disease; AMPK, adenosine monophosphate-acti-
vated protein kinase; ARC, arcuate hypothalamic nucleus; AVP,
arginine vasopressin; CKIε, casein kinase I epsilon; CR, calorie
restriction; CREB, cAMP response element-binding protein; DMH,
dorsomedial hypothalamus; DR, dietary restriction; GRP, gastrin
releasing peptide; HAT, histone acetyltransferase; HD, Huntington’s
disease; HIF1α, hypoxia-inducible factor 1α; HRE, hypoxia-respon-
sive element; LC, locus coeruleus; LH, lateral hypothalamus; mTOR,
mammalian target of rapamycin; MUA, multiunit neural activity;
NAMPT, Nicotinamide phosphoribosyltransferase; NMS, neu-
romedin S; NT, neurotensin; PD, Parkinson’s disease; PK2, proki-
neticin 2; PVN, paraventricular hypothalamic nucleus; RBD, REM
behavior disorder; RHT, retinohypothalamic tract; SCN, suprachias-
matic nucleus; sPVZ, subparaventricular zone; VIP, vasoactive
intestinal peptide; VLPO, ventrolateral preoptic area
COMPLIANCE WITH ETHICAL STANDARDS
Fang Liu and Hung-Chun Chang declare that they have no conﬂict
of interest. This article does not contain any studies with human or
animal subjects performed by any of the authors.
OPEN ACCESS
This article is distributed under the terms of the Creative Commons
Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to
the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made.
REFERENCES
Abrahamson EE, Moore RY (2001) Suprachiasmatic nucleus in the
mouse: retinal innervation, intrinsic organization and efferent
projections. Brain Res 916:172–191
REVIEW Fang Liu and Hung-Chun Chang









Abrahamson EE, Leak RK, Moore RY (2001) The suprachiasmatic
nucleus projects to posterior hypothalamic arousal systems.
NeuroReport 12:435–440
Adamovich Y, Ladeuix B, Golik M, Koeners MP, Asher G (2017)
Rhythmic oxygen levels reset circadian clocks through HIF1al-
pha. Cell Metab. doi:10.1016/j.cmet.2016.09.014
Aida R, Moriya T, Araki M, Akiyama M, Wada K, Wada E, Shibata S
(2002) Gastrin-releasing peptide mediates photic entrainable
signals to dorsal subsets of suprachiasmatic nucleus via induc-
tion of period gene in mice. Mol Pharmacol 61:26–34
Antle MC, Silver R (2005) Orchestrating time: arrangements of the
brain circadian clock. Trends Neurosci 28:145–151
Antoch MP, Gorbacheva VY, Vykhovanets O, Toshkov IA, Kondratov
RV, Kondratova AA, Lee C, Nikitin AY (2008) Disruption of the
circadian clock due to the clock mutation has discrete effects on
aging and carcinogenesis. Cell Cycle 7:1197–1204
Arnulf I, Nielsen J, Lohmann E, Schiefer J, Wild E, Jennum P,
Konofal E, Walker M, Oudiette D, Tabrizi S et al (2008) Rapid eye
movement sleep disturbances in Huntington disease. Arch
Neurol 65:482–488
Asher G, Sassone-Corsi P (2015) Time for food: the intimate
interplay between nutrition, metabolism, and the circadian clock.
Cell 161:84–92
Asher G, Gatﬁeld D, Stratmann M, Reinke H, Dibner C, Kreppel F,
Mostoslavsky R, Alt FW, Schibler U (2008) SIRT1 regulates
circadian clock gene expression through PER2 deacetylation.
Cell 134:317–328
Aston-Jones G, Chen S, Zhu Y, Oshinsky ML (2001) A neural circuit
for circadian regulation of arousal. Nat Neurosci 4:732–738
Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F,
Overeem S, van Duinen S, Lammers GJ, Swaab D, Roos R
(2008) Hypocretin and melanin-concentrating hormone in
patients with Huntington disease. Brain Pathol 18:474–483
Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello
TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R et al (2009)
The PRIAMO study: a multicenter assessment of nonmotor
symptoms and their impact on quality of life in Parkinson’s
disease. Mov Dis 24:1641–1649
Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA (2016)
Metformin as a tool to target aging. Cell Metab 23:1060–1065
Bass J, Takahashi JS (2010) Circadian integration of metabolism
and energetics. Science 330:1349–1354
Bollinger T, Schibler U (2014) Circadian rhythms—from genes to
physiology and disease. Swiss Med Wkly 144:w13984
Bonkowski MS, Sinclair DA (2016) Slowing ageing by design: the
rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell
Biol 17:679–690
Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004)
Stages in the development of Parkinson’s disease-related
pathology. Cell Tissue Res 318:121–134
Bray MS, Young ME (2007) Circadian rhythms in the development of
obesity: potential role for the circadian clock within the adipocyte.
Obes Rev 8:169–181
Breen DP, Vuono R, Nawarathna U, Fisher K, Shneerson JM, Reddy
AB, Barker RA (2014) Sleep and circadian rhythm regulation in
early Parkinson disease. JAMA Neurol 71:589–595
Cai Y, Liu S, Sothern RB, Xu S, Chan P (2010) Expression of clock
genes Per1 and Bmal1 in total leukocytes in health and
Parkinson’s disease. Eur J Neurol 17:550–554
Cao R, Robinson B, Xu H, Gkogkas C, Khoutorsky A, Alain T,
Yanagiya A, Nevarko T, Liu AC, Amir S et al (2013) Translational
control of entrainment and synchrony of the suprachiasmatic
circadian clock by mTOR/4E-BP1 signaling. Neuron 79:712–724
Chang HC, Guarente L (2013) SIRT1 mediates central circadian
control in the SCN by a mechanism that decays with aging. Cell
153:1448–1460
Chang HC, Guarente L (2014) SIRT1 and other sirtuins in
metabolism. Trends Endocrinol Metab 25:138–145
Chawla A, Lazar MA (1993) Induction of Rev-ErbA alpha, an orphan
receptor encoded on the opposite strand of the alpha-thyroid
hormone receptor gene, during adipocyte differentiation. J Biol
Chem 268:16265–16269
Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW,
DiTacchio L, Atkins AR, Glass CK et al (2012) Regulation of
circadian behaviour and metabolism by REV-ERB-alpha and
REV-ERB-beta. Nature 485:123–127
Choi HJ, Lee CJ, Schroeder A, Kim YS, Jung SH, Kim JS, Kim DY,
Son EJ, Han HC, Hong SK et al (2008) Excitatory actions of
GABA in the suprachiasmatic nucleus. J Neurosci 28:5450–5459
Chou TC, Bjorkum AA, Gaus SE, Lu J, Scammell TE, Saper CB
(2002) Afferents to the ventrolateral preoptic nucleus. J Neurosci
22:977–990
Chou TC, Scammell TE, Gooley JJ, Gaus SE, Saper CB, Lu J (2003)
Critical role of dorsomedial hypothalamic nucleus in a wide range of
behavioral circadian rhythms. J Neurosci 23:10691–10702
Choudhary C, Weinert BT, Nishida Y, Verdin E, Mann M (2014) The
growing landscape of lysine acetylation links metabolism and cell
signalling. Nat Rev Mol Cell Biol 15:536–550
Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka
KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz
JW et al (2009) Caloric restriction delays disease onset and
mortality in rhesus monkeys. Science 325:201–204
Colman RJ, Beasley TM, Kemnitz JW, Johnson SC, Weindruch R,
Anderson RM (2014) Caloric restriction reduces age-related and
all-cause mortality in rhesus monkeys. Nat Commun 5:3557
Colwell CS (2011) Linking neural activity and molecular oscillations
in the SCN. Nat Rev Neurosci 12:553–569
Davidson AJ, Straume M, Block GD, Menaker M (2006) Daily timed
meals dissociate circadian rhythms in hepatoma and healthy host
liver. Int J Cancer 118:1623–1627
De Jeu M, Pennartz C (2002) Circadian modulation of GABA
function in the rat suprachiasmatic nucleus: excitatory effects
during the night phase. J Neurophysiol 87:834–844
Dibner C, Schibler U, Albrecht U (2010) The mammalian circadian
timing system: organization and coordination of central and
peripheral clocks. Annu Rev Physiol 72:517–549
Dubrovsky YV, Samsa WE, Kondratov RV (2010) Deﬁciency of
circadian protein CLOCK reduces lifespan and increases age-
related cataract development in mice. Aging 2:936–944
Duffy JF, Czeisler CA (2002) Age-related change in the relationship
between circadian period, circadian phase, and diurnal prefer-
ence in humans. Neurosci Lett 318:117–120
Circadian clock and biological clock of aging REVIEW









Eckel-Mahan KL, Patel VR, de Mateo S, Orozco-Solis R, Ceglia NJ,
Sahar S, Dilag-Penilla SA, Dyar KA, Baldi P, Sassone-Corsi P
(2013) Reprogramming of the circadian clock by nutritional
challenge. Cell 155:1464–1478
Everett LJ, Lazar MA (2014) Nuclear receptor Rev-erbalpha: up,
down, and all around. Trends Endocrinol Metab 25:586–592
Fahrenkrug J, Popovic N, Georg B, Brundin P, Hannibal J (2007)
Decreased VIP and VPAC2 receptor expression in the biological
clock of the R6/2 Huntington’s disease mouse. J Mol Neurosci
31:139–148
Farajnia S, Michel S, Deboer T, vanderLeest HT, Houben T, Rohling
JH, Ramkisoensing A, Yasenkov R, Meijer JH (2012) Evidence
for neuronal desynchrony in the aged suprachiasmatic nucleus
clock. J Neurosci 32:5891–5899
Fifel K, Cooper HM (2014) Loss of dopamine disrupts circadian
rhythms in a mouse model of Parkinson’s disease. Neurobiol Dis
71:359–369
Filipski E, King VM, Li X, Granda TG, Mormont MC, Claustrat B,
Hastings MH, Levi F (2003) Disruption of circadian coordination
accelerates malignant growth in mice. Pathol Biol 51:216–219
Fontana L, Partridge L (2015) Promoting health and longevity
through diet: from model organisms to humans. Cell 161:106–118
Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van
Duinen SG, Lammers GJ, Swaab DF (2007) Hypocretin (orexin)
loss in Parkinson’s disease. Brain 130:1577–1585
Froy O (2013) Circadian aspects of energy metabolism and aging.
Ageing Res Rev 12:931–940
Fu L, Pelicano H, Liu J, Huang P, Lee C (2002) The circadian gene
Period2 plays an important role in tumor suppression and DNA
damage response in vivo. Cell 111:41–50
Gabery S, Murphy K, Schultz K, Loy CT, McCusker E, Kirik D,
Halliday G, Petersen A (2010) Changes in key hypothalamic
neuropeptide populations in Huntington disease revealed by
neuropathological analyses. Acta Neuropathol 120:777–788
Gibson EM, Williams WP 3rd, Kriegsfeld LJ (2009) Aging in the
circadian system: considerations for health, disease prevention
and longevity. Exp Gerontol 44:51–56
Golombek DA, Rosenstein RE (2010) Physiology of circadian
entrainment. Physiol Rev 90:1063–1102
Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman
L, White JP, Teodoro JS, Wrann CD, Hubbard BP et al (2013)
Declining NAD(+) induces a pseudohypoxic state disrupting
nuclear-mitochondrial communication during aging. Cell
155:1624–1638
Goodman AO, Barker RA (2010) How vital is sleep in Huntington’s
disease? J Neurol 257:882–897
Guarente L (2013) Calorie restriction and sirtuins revisited. Genes
Dev 27:2072–2085
Hamada T, Antle MC, Silver R (2004) Temporal and spatial
expression patterns of canonical clock genes and clock-con-
trolled genes in the suprachiasmatic nucleus. Eur J Neurosci
19:1741–1748
Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K,
Nadon NL, Wilkinson JE, Frenkel K, Carter CS et al (2009)
Rapamycin fed late in life extends lifespan in genetically
heterogeneous mice. Nature 460:392–395
Herskovits AZ, Guarente L (2014) SIRT1 in neurodevelopment and
brain senescence. Neuron 81:471–483
Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata
Y, Sassone-Corsi P (2007) CLOCK-mediated acetylation of
BMAL1 controls circadian function. Nature 450:1086–1090
Hofman MA, Swaab DF (1994) Alterations in circadian rhythmicity of
the vasopressin-producing neurons of the human suprachias-
matic nucleus (SCN) with aging. Brain Res 651:134–142
Hofman MA, Swaab DF (1995) Inﬂuence of aging on the seasonal
rhythm of the vasopressin-expressing neurons in the human
suprachiasmatic nucleus. Neurobiol Aging 16:965–971
Hofman MA, Swaab DF (2006) Living by the clock: the circadian
pacemaker in older people. Ageing Res Rev 5:33–51
Hofman MA, Zhou JN, Swaab DF (1996) No evidence for a diurnal
vasoactive intestinal polypeptide (VIP) rhythm in the human
suprachiasmatic nucleus. Brain Res 722:78–82
Hosoda H, Kato K, Asano H, Ito M, Kato H, Iwamoto T, Suzuki A,
Masushige S, Kida S (2009) CBP/p300 is a cell type-speciﬁc
modulator of CLOCK/BMAL1-mediated transcription. Mol Brain
2:34
Hurd MW, Ralph MR (1998) The signiﬁcance of circadian organi-
zation for longevity in the golden hamster. J Biol Rhythms
13:430–436
Iranzo A (2013) Parkinson disease and sleep: sleep-wake changes
in the premotor stage of Parkinson disease; impaired olfaction
and other prodromal features. Curr Neurol Neurosci Rep 13:373
Jung-Hynes B, Reiter RJ, Ahmad N (2010) Sirtuins, melatonin and
circadian rhythms: building a bridge between aging and cancer.
J Pineal Res 48:9–19
Kaeberlein M, Rabinovitch PS, Martin GM (2015) Healthy aging: the
ultimate preventative medicine. Science 350:1191–1193
Kalsbeek A, Palm IF, La Fleur SE, Scheer FA, Perreau-Lenz S,
Ruiter M, Kreier F, Cailotto C, Buijs RM (2006) SCN outputs and
the hypothalamic balance of life. J Biol Rhythms 21:458–469
Khapre RV, Kondratova AA, Patel S, Dubrovsky Y, Wrobel M,
Antoch MP, Kondratov RV (2014) BMAL1-dependent regulation
of the mTOR signaling pathway delays aging. Aging 6:48–57
Kolker DE, Fukuyama H, Huang DS, Takahashi JS, Horton TH,
Turek FW (2003) Aging alters circadian and light-induced
expression of clock genes in golden hamsters. J Biol Rhythms
18:159–169
Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV,
Antoch MP (2006) Early aging and age-related pathologies in
mice deﬁcient in BMAL1, the core component of the circadian
clock. Genes Dev 20:1868–1873
Kondratova AA, Kondratov RV (2012) The circadian clock and
pathology of the ageing brain. Nat Rev Neurosci 13:325–335
Kudo T, Loh DH, Truong D, Wu Y, Colwell CS (2011) Circadian
dysfunction in a mouse model of Parkinson’s disease. Exp Neurol
232:66–75
Lamia KA, Sachdeva UM, DiTacchio L, Williams EC, Alvarez JG,
Egan DF, Vasquez DS, Juguilon H, Panda S, Shaw RJ et al
(2009) AMPK regulates the circadian clock by cryptochrome
phosphorylation and degradation. Science 326:437–440
Lande-Diner L, Boyault C, Kim JY, Weitz CJ (2013) A positive
feedback loop links circadian clock factor CLOCK-BMAL1 to the
REVIEW Fang Liu and Hung-Chun Chang









basic transcriptional machinery. Proc Natl Acad Sci USA
110:16021–16026
Lee CC (2005) The circadian clock and tumor suppression by
mammalian period genes. Methods Enzymol 393:852–861
Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM
(2001) Posttranslational mechanisms regulate the mammalian
circadian clock. Cell 107:855–867
Lee JH, Bliwise DL, Ansari FP, Goldstein FC, Cellar JS, Lah JJ,
Levey AI (2007) Daytime sleepiness and functional impairment in
Alzheimer disease. Am J Geriatr Psychiatry 15:620–626
Li H, Satinoff E (1998) Fetal tissue containing the suprachiasmatic
nucleus restores multiple circadian rhythms in old rats. Am J
Physiol 275:R1735–R1744
Li XM, Delaunay F, Dulong S, Claustrat B, Zampera S, Fujii Y, Teboul
M, Beau J, Levi F (2010) Cancer inhibition through circadian
reprogramming of tumor transcriptome with meal timing. Cancer
Res 70:3351–3360
Li J, Kim SG, Blenis J (2014) Rapamycin: one drug, many effects.
Cell Metab 19:373–379
Lipton JO, Yuan ED, Boyle LM, Ebrahimi-Fakhari D, Kwiatkowski E,
Nathan A, Guttler T, Davis F, Asara JM, Sahin M (2015) The
circadian protein BMAL1 regulates translation in response to
S6K1-mediated phosphorylation. Cell 161:1138–1151
Lopez M, Nogueiras R, Tena-Sempere M, Dieguez C (2016)
Hypothalamic AMPK: a canonical regulator of whole-body energy
balance. Nat Rev Endocrinol 12:421–432
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G
(2013) The hallmarks of aging. Cell 153:1194–1217
Lopez-Otin C, Galluzzi L, Freije JM, Madeo F, Kroemer G (2016)
Metabolic control of longevity. Cell 166:802–821
Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH,
Ivanova G, Omura C, Mo S, Vitaterna MH et al (2010) Disruption
of the clock components CLOCK and BMAL1 leads to hypoinsuli-
naemia and diabetes. Nature 466:627–631
Masri S, Rigor P, Cervantes M, Ceglia N, Sebastian C, Xiao CY,
Roqueta-Rivera M, Deng CX, Osborne TF, Mostoslavsky R et al
(2014) Partitioning circadian transcription by SIRT6 leads to
segregated control of cellular metabolism. Cell 158:659–672
Mattis J, Sehgal A (2016) Circadian rhythms, sleep, and disorders of
aging. Trends Endocrinol Metab 27:192–203
Meyer-Spasche A, Reed HE, Piggins HD (2002) Neurotensin phase-
shifts the ﬁring rate rhythm of neurons in the rat suprachiasmatic
nuclei in vitro. Eur J Neurosci 16:339–344
Moore RY, Speh JC (1993) GABA is the principal neurotransmitter of
the circadian system. Neurosci Lett 150:112–116
Morin LP, Allen CN (2006) The circadian visual system, 2005. Brain
Res Rev 51:1–60
Morin LP, Shivers KY, Blanchard JH, Muscat L (2006) Complex
organization of mouse and rat suprachiasmatic nucleus. Neuro-
science 137:1285–1297
Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA,
Maywood ES (2005) Disintegration of the sleep-wake cycle and
circadian timing in Huntington’s disease. J Neurosci 25:157–163
Nadon NL (2006) Exploiting the rodent model for studies on the
pharmacology of lifespan extension. Aging Cell 5:9–15
Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D,
Guarente LP, Sassone-Corsi P (2008) The NAD+-dependent
deacetylase SIRT1 modulates CLOCK-mediated chromatin
remodeling and circadian control. Cell 134:329–340
Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P
(2009) Circadian control of the NAD+ salvage pathway by
CLOCK-SIRT1. Science 324:654–657
Nakamura W, Yamazaki S, Takasu NN, Mishima K, Block GD (2005)
Differential response of Period 1 expression within the suprachi-
asmatic nucleus. J Neurosci 25:5481–5487
Nakamura TJ, Nakamura W, Yamazaki S, Kudo T, Cutler T, Colwell
CS, Block GD (2011) Age-related decline in circadian output.
J Neurosci 31:10201–10205
Novak CM, Nunez AA (2000) A sparse projection from the
suprachiasmatic nucleus to the sleep active ventrolateral preoptic
area in the rat. NeuroReport 11:93–96
Ozturk N, Lee JH, Gaddameedhi S, Sancar A (2009) Loss of
cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl
Acad Sci USA 106:2841–2846
Panda S, Hogenesch JB, Kay SA (2002) Circadian rhythms from
ﬂies to human. Nature 417:329–335
Peek CB, Levine DC, Cedernaes J, Taguchi A, Kobayashi Y, Tsai
SJ, Bonar NA, McNulty MR, Ramsey KM, Bass J (2017)
Circadian clock interaction with HIF1alpha mediates oxygenic
metabolism and anaerobic glycolysis in skeletal muscle. Cell
Metab. doi:10.1016/j.cmet.2016.09.010
Penev PD, Kolker DE, Zee PC, Turek FW (1998) Chronic circadian
desynchronization decreases the survival of animals with car-
diomyopathic heart disease. Am J Physiol 275:H2334–H2337
Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D,
Albrecht U, Schibler U (2002) The orphan nuclear receptor REV-
ERBalpha controls circadian transcription within the positive limb
of the mammalian circadian oscillator. Cell 110:251–260
Pulivarthy SR, Tanaka N, Welsh DK, De Haro L, Verma IM, Panda S
(2007) Reciprocity between phase shifts and amplitude changes
in the mammalian circadian clock. Proc Natl Acad Sci USA
104:20356–20361
Puram RV, Kowalczyk MS, de Boer CG, Schneider RK, Miller PG,
McConkey M, Tothova Z, Tejero H, Heckl D, Jaras M et al (2016)
Core circadian clock genes regulate leukemia stem cells in AML.
Cell 165:303–316
Qu Z, Zhang H, Huang M, Shi G, Liu Z, Xie P, Li H, Wang W, Xu G,
Zhang Y et al (2016) Loss of ZBTB20 impairs circadian output
and leads to unimodal behavioral rhythms. eLife 5:e17171
Ramadori G, Fujikawa T, Fukuda M, Anderson J, Morgan DA,
Mostoslavsky R, Stuart RC, Perello M, Vianna CR, Nillni EA et al
(2010) SIRT1 deacetylase in POMC neurons is required for
homeostatic defenses against diet-induced obesity. Cell Metab
12:78–87
Ramadori G, Fujikawa T, Anderson J, Berglund ED, Frazao R,
Michan S, Vianna CR, Sinclair DA, Elias CF, Coppari R (2011)
SIRT1 deacetylase in SF1 neurons protects against metabolic
imbalance. Cell Metab 14:301–312
Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y,
Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C et al (2009)
Circadian clock feedback cycle through NAMPT-mediated NAD+
biosynthesis. Science 324:651–654
Reddy AB, Rey G (2014) Metabolic and nontranscriptional circadian
clocks: eukaryotes. Annu Rev Biochem 83:165–189
Circadian clock and biological clock of aging REVIEW









Reppert SM, Weaver DR (2002) Coordination of circadian timing in
mammals. Nature 418:935–941
Riera CE, Dillin A (2015) Tipping the metabolic scales towards
increased longevity in mammals. Nat Cell Biol 17:196–203
Roozendaal B, van Gool WA, Swaab DF, Hoogendijk JE, Mirmiran M
(1987) Changes in vasopressin cells of the rat suprachiasmatic
nucleus with aging. Brain Res 409:259–264
Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S,
Hogenesch JB, Fitzgerald GA (2004) BMAL1 and CLOCK, two
essential components of the circadian clock, are involved in
glucose homeostasis. PLoS Biol 2:e377
Sahar S, Sassone-Corsi P (2009) Metabolism and cancer: the
circadian clock connection. Nat Rev Cancer 9:886–896
Satlin A, Volicer L, Stopa EG, Harper D (1995) Circadian locomotor
activity and core-body temperature rhythms in Alzheimer’s
disease. Neurobiol Aging 16:765–771
Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P,
Naik KA, FitzGerald GA, Kay SA, Hogenesch JB (2004) A
functional genomics strategy reveals Rora as a component of the
mammalian circadian clock. Neuron 43:527–537
Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED,
Yamada KA, Imai S (2013) Sirt1 extends life span and delays
aging in mice through the regulation of Nk2 homeobox 1 in the
DMH and LH. Cell Metab 18:416–430
Scarbrough K, Losee-Olson S, Wallen EP, Turek FW (1997) Aging
and photoperiod affect entrainment and quantitative aspects of
locomotor behavior in Syrian hamsters. Am J Physiol 272:
R1219–R1225
Shimba S, Ishii N, Ohta Y, Ohno T, Watabe Y, Hayashi M, Wada T,
Aoyagi T, Tezuka M (2005) Brain and muscle Arnt-like protein-1
(BMAL1), a component of the molecular clock, regulates adipo-
genesis. Proc Natl Acad Sci USA 102:12071–12076
Shinohara K, Hiruma H, Funabashi T, Kimura F (2000) GABAergic
modulation of gap junction communication in slice cultures of the
rat suprachiasmatic nucleus. Neuroscience 96:591–596
Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T,
Shin Y, Liu J, Cameron MD, Noel R et al (2012) Regulation of
circadian behaviour and metabolism by synthetic REV-ERB
agonists. Nature 485:62–68
Stashi E, Lanz RB, Mao J, Michailidis G, Zhu B, Kettner NM, Putluri
N, Reineke EL, Reineke LC, Dasgupta S et al (2014) SRC-2 is an
essential coactivator for orchestrating metabolism and circadian
rhythm. Cell reports 6:633–645
Sterniczuk R, Antle MC, Laferla FM, Dyck RH (2010a) Character-
ization of the 3xTg-AD mouse model of Alzheimer’s disease: part
2. Behavioral and cognitive changes. Brain Res 1348:149–155
Sterniczuk R, Dyck RH, Laferla FM, Antle MC (2010b) Character-
ization of the 3xTg-AD mouse model of Alzheimer’s disease: part
1. Circadian changes. Brain Res 1348:139–148
Swaab DF, Fliers E, Partiman TS (1985) The suprachiasmatic
nucleus of the human brain in relation to sex, age and senile
dementia. Brain Res 342:37–44
Torra IP, Tsibulsky V, Delaunay F, Saladin R, Laudet V, Fruchart JC,
Kosykh V, Staels B (2000) Circadian and glucocorticoid
regulation of Rev-erbalpha expression in liver. Endocrinology
141:3799–3806
Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E,
Laposky A, Losee-Olson S, Easton A, Jensen DR et al (2005)
Obesity and metabolic syndrome in circadian Clock mutant mice.
Science 308:1043–1045
Um JH, Yang S, Yamazaki S, Kang H, Viollet B, Foretz M, Chung JH
(2007) Activation of 5’-AMP-activated kinase with diabetes drug
metformin induces casein kinase Iepsilon (CKIepsilon)-depen-
dent degradation of clock protein mPer2. J Biol Chem
282:20794–20798
Valentinuzzi VS, Scarbrough K, Takahashi JS, Turek FW (1997)
Effects of aging on the circadian rhythm of wheel-running activity
in C57BL/6 mice. Am J Physiol 273:R1957–R1964
van Someren EJ, Hagebeuk EE, Lijzenga C, Scheltens P, de Rooij
SE, Jonker C, Pot AM, Mirmiran M, Swaab DF (1996) Circadian
rest-activity rhythm disturbances in Alzheimer’s disease. Biol
Psychiatry 40:259–270
Videnovic A, Lazar AS, Barker RA, Overeem S (2014) ‘The clocks
that time us’–circadian rhythms in neurodegenerative disorders.
Nat Rev Neurol 10:683–693
Weinert D (2000) Age-dependent changes of the circadian system.
Chronobiol Int 17:261–283
WelshDK, Takahashi JS,KaySA (2010)Suprachiasmatic nucleus: cell
autonomy and network properties. Annu Rev Physiol 72:551–577
Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair
D (2004) Sirtuin activators mimic caloric restriction and delay
ageing in metazoans. Nature 430:686–689
Wu Y, Tang D, Liu N, Xiong W, Huang H, Li Y, Ma Z, Zhao H, Chen P,
Qi X et al (2017) Reciprocal regulation between the circadian
clock and hypoxia signaling at the genome level in mammals.
Cell Metab. doi:10.1016/j.cmet.2016.09.009
Wyse CA, Coogan AN (2010) Impact of aging on diurnal expression
patterns of CLOCK and BMAL1 in the mouse brain. Brain Res
1337:21–31
Yamazaki S, Straume M, Tei H, Sakaki Y, Menaker M, Block GD
(2002) Effects of aging on central and peripheral mammalian
clocks. Proc Natl Acad Sci USA 99:10801–10806
Yan L, Okamura H (2002) Gradients in the circadian expression of
Per1 and Per2 genes in the rat suprachiasmatic nucleus. Eur J
Neurosci 15:1153–1162
Yan L, Karatsoreos I, Lesauter J, Welsh DK, Kay S, Foley D, Silver R
(2007) Exploring spatiotemporal organization of SCN circuits.
Cold Spring Harb Symp Quant Biol 72:527–541
Yoon IY, Kripke DF, Elliott JA, Youngstedt SD, Rex KM, Hauger RL
(2003) Age-related changes of circadian rhythms and sleep-wake
cycles. J Am Geriatr Soc 51:1085–1091
Zhang EE, Liu Y, Dentin R, Pongsawakul PY, Liu AC, Hirota T,
Nusinow DA, Sun X, Landais S, Kodama Y et al (2010)
Cryptochrome mediates circadian regulation of cAMP signaling
and hepatic gluconeogenesis. Nat Med 16:1152–1156
Zhou JN, Hofman MA, Swaab DF (1995) VIP neurons in the human
SCN in relation to sex, age, and Alzheimer’s disease. Neurobiol
Aging 16:571–576
REVIEW Fang Liu and Hung-Chun Chang
© The Author(s) 2017. This article is published with open access at Springerlink.com and journal.hep.com.cn
P
ro
te
in
&
C
e
ll
